Tagoral medication

Information about TRUVADA and ATRIPLA delisting

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Sex a key part of life for people over 65, study says

S

Guardian, Thu 3 May 2018 21.08 AEST Sex is not only a pursuit of the young and carefree but also a key part of life for adults in their later years, a new poll has revealed – putting paid to the trope that action stops as pensions loom. A US survey has found that 40% of those aged between 65 and 80 report being sexually active, with more than half of those who have a partner saying they still...

Do Estrogen Therapies Affect Sexual Function in Early Postmenopause?

D

JAMA Internal Medicine, 2017 Transdermal estrogen therapy delivered through the skin modestly improved sexual function in early postmenopausal women, according to an article published by JAMA Internal Medicine. Declining estrogen levels around the menopausal transition are commonly associated with sexual dysfunction, which can be an important determinant of women’s health and quality of life. In...

Sex drive: Understanding why low libido is a common problem in middle-aged women

S

ABC Health & Wellbeing, Sunday at 08:08 While it’s hard to know exactly how many women experience low libido, it seems it might be more common than previously thought. Almost 70 per cent of Australian women aged 40-65 years old reported a lack of sexual desire in a recent study published in the Journal of Sexual Medicine. The authors noted this was “somewhat higher” than...

Hepatitis C treatment can be provided successfully at syringe programme sites

H

infohep.org, 18 April 2017
Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City. Expanding treatment for this population could reduce hepatitis C virus (HCV) transmission and ultimately help eliminate hepatitis C as a public health threat.

Read more here 

‘Shock and kill’ therapy offers fresh hope for HIV cure, researchers say

PBS Newshour, December 15, 2016 at 11:00 AM EST A new small-scale human trial of the promising “shock and kill” treatment is starting this week in New York and two sister sites, in Germany and Denmark.  Another small human study will start in January, followed by a larger human shock and kill trial in June. The HIV research community is increasingly optimistic about this approach to eradicating...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories